Nationwide Children's Events & Announcements
Viewing: 71-80 of 974 | All
Sep 18, 2023
Nationwide Children’s Hospital Opening New Vision Center, School Health Center in Reynoldsburg, Mt. Vernon
Nationwide Children’s Hospital is opening a new school-based health center at Mount Vernon City Schools and a vision center at Reynoldsburg City Schools as part of ongoing efforts to increase access to health care for students.
Sep 18, 2023
Study Shows Nearly 300% Increase in ADHD Medication Errors
In a new study, published today in Pediatrics, researchers at the Center for Injury Research and Policy and Central Ohio Poison Center at Nationwide Children’s Hospital investigated the characteristics and trends of out-of-hospital ADHD medication errors among people younger than 20 years old reported to U.S. poison centers from 2000 through 2021.
Sep 11, 2023
$6.95 Million FDA Grant to Help Create Medical Devices Just for Children
The Food and Drug Administration (FDA) announced a $6.95 million grant to be distributed over five years to create a new consortium led by investigators from Nationwide Children’s Hospital, The Ohio State University, Cleveland Clinic Children’s, and Cincinnati Children’s to help increase the number of pediatric medical devices across the nation.
Aug 08, 2023
From Bench to Bedside: Patient with Duchenne Muscular Dystrophy Receives First Dose of Gene Therapy Developed at Nationwide Children’s Hospital
In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children’s, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently approved gene therapy for Duchenne muscular dystrophy at Nationwide Children’s Hospital, where the therapy was invented and initially tested.
Jul 17, 2023
Nationwide Children’s Hospital Names Ray Bignall, MD, Chief Diversity and Health Equity Officer
Nationwide Children’s Hospital announced today that O. N. Ray Bignall II, MD, FAAP, FASN, has been named the hospital’s chief diversity and health equity officer.
Jun 22, 2023
FDA Approves First Gene Therapy Treatment for Duchenne Muscular Dystrophy Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its accelerated approval of SRP-9001/ELEVIDYS for Duchenne muscular dystrophy (DMD) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.
Jun 21, 2023
Nationwide Children’s Hospital Marks A Decade as One of the Nation’s Best
Nationwide Children’s Hospital has been named to U.S. News & World Report’s Best Children’s Hospitals Honor Roll for the 10th consecutive year. The Honor Roll is a top distinction awarded to only 10 children’s hospitals nationwide recognized by U.S. News as the “Best of the Best.” Nationwide Children’s is ranked sixth on the 2023-24 Honor Roll list.
Jun 13, 2023
Mapping the 3D Structure of Rhabdomyosarcoma Chromatin
In a paper published in Nucleic Acids Research Cancer (NAR Cancer), researchers from the Center for Childhood Cancer Research at Nationwide Children’s and their collaborators report a comprehensive 3D chromatin structural analysis and characterization of rhabdomyosarcoma (RMS).
Jun 05, 2023
Nelson Weichold Named Chief Financial Officer at Nationwide Children’s
Nelson Weichold, MHA, has been named chief financial officer at Nationwide Children’s Hospital, effective June 5.
May 19, 2023
Nationwide Children’s Hospital Becomes Certified Site for Gene Therapy for Transfusion-Dependent Beta Thalassemia
Nationwide Children’s Hospital has been designated a qualified treatment center for Zynteglo® (betibeglogene autotemcel), a a gene therapy approved for the treatment of people with beta thalassemia who require regular red blood cell transfusions.